[1] Walsh NC, Kenney LL, Jangalwe S, et al. Humanized Mouse Models of Clinical Disease. Annu Rev Pathol, 2017, 12: 187-215.
[2] 张海斌, 何志颖, 杨广顺. 人源化肝脏嵌合体小鼠的研究进展. 中华肝脏病杂志, 2011, 19: 398-400.
[3] Grompe M, Strom S. Mice With Human Livers. Gastroenterology, 2013, 145: 1209-1214.
[4] Xu D, Peltz G. Can Humanized Mice Predict Drug "Behavior" in Humans? Annu Rev Pharmacol Toxicol, 2016, 56: 323-338.
[5] Peltz G. Can 'humanized' mice improve drug development in the 21st century? Trends Pharmacol Sci, 2013, 34: 255-260.
[6] Kenney LL, Shultz LD, Greiner DL, et al. Humanized Mouse Models for Transplant Immunology. Am J Transplant, 2016, 16: 389-397.
[7] Ito R, Takahashi T, Katano I, et al. Current advances in humanized mouse models. Cell Mol Immunol, 2012, 9: 208-214.
[8] Azuma H, Paulk N, Ranade A, et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol, 2007, 25: 903-910.
[9] Gramignoli R, Tahan V, Dorko K, et al. New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res, 2013, 11: 563-573.
[10] Bissig-Choisat B, Wang L, Legras X, et al. Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun, 2015, 6: 7339.
[11] Wu H, Zhou X, Fu GB, et al. Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion. Cell Res, 2017,27:709-712.
[12] Vaughan AM, Mikolajczak SA, Wilson EM, et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest, 2012, 122: 3618-3628.
[13] Billerbeck E, Mommersteeg MC, Shlomai A, et al. Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol, 2016, 65: 334-343.
[14] Bility MT, Zhang L, Washburn ML, et al. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat Protoc, 2012, 7: 1608-1617.
[15] Washburn ML, Bility MT, Zhang L, et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology, 2011, 140: 1334-1344.
[16] Mikula M, Fuchs E, Huber H, et al. Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation. Hepatology, 2004, 39: 628-634.
[17] Higuchi Y, Kawai K, Yamazaki H, et al. The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice. Xenobiotica, 2014, 44: 146-153.
[18] Nagamoto Y, Takayama K, Tashiro K, et al. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. Cell Transplant, 2015, 24: 1127-1138.
[19] Du Y, Wang J, Jia J, et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell, 2014, 14: 394-403.
[20] Huang P, Zhang L, Gao Y, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell, 2014, 14: 370-384.
[21] Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol, 2004, 165: 901-912.
[22] Mailly L, Xiao F, Lupberger J, et al. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody. Nat Biotechnol, 2015, 33: 549-554.
[23] 傅忠星, 杨帆, 王灵, 等. 人鼠嵌合肝小鼠模型的建立及在HBV致病研究中的应用. 传染病信息,2017, 30: 75-81.
[24] Scheer N, Wilson ID. A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity. Drug Discov Today, 2016, 21: 250-263.
[25] Grompe M, al-Dhalimy M, Finegold M, et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev, 1993, 7: 2298-2307.
[26] Bissig KD, Le TT, Woods NB, et al. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A, 2007, 104: 20507-20511.
[27] Ardiani A, Sanchez-Bonilla M, Black ME. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo. Cancer Gene Ther, 2010, 17: 86-96.
[28] Hasegawa M, Kawai K, Mitsui T, et al. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun, 2011, 405: 405-410.
[29] Xu D, Wu M, Nishimura S, et al. Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity. J Pharmacol Exp Ther, 2015, 352: 274-280.
[30] Zhang RR, Zheng YW, Li B, et al. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities. Stem Cell Res Ther, 2015, 6: 49.
[31] Soulard V, Bosson-Vanga H, Lorthiois A, et al. Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice. Nat Commun, 2015, 6: 7690.
[32] Mikolajczak SA, Vaughan AM, Kangwanrangsan N, et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe, 2015, 17: 526-535.
[33] Foquet L, Hermsen CC, Verhoye L, et al. Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model. J Antimicrob Chemother, 2015, 70: 1784-1787.
[34] Jaiswal S, Sharma A, Shukla M, et al. Novel pre-clinical methodologies for pharmacokinetic drug-drug interaction studies: spotlight on "humanized" animal models. Drug Metab Rev, 2014, 46: 475-493.
[35] Ellis EC, Naugler WE, Parini P, et al. Mice with chimeric livers are an improved model for human lipoprotein metabolism. PloS one, 2013, 8: e78550. |
